Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work

Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work

by , , | Dec 20, 2022 | C19 (COVID-19), VC19 (VACCINES COVID-19), VE (VACCINE EFFECTIVENESS), VS (VACCINE SAFETY)

Motivation Supplementary appendix to the Pfizer phase 2/3 trial 2 month report – “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine” published in the NEJM in December 2020. Author Polack FP, Thomas SJ, Kitchin N, et al. Submitted By Dr Herman...